Yongqiang Wei

Department of Hematology, Southern Medical University

Affiliated withSouthern Medical University

Research Area

Biography

Yongqiang Wei has not added Biography.
If you are Yongqiang Wei and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
[Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA\| PubMed ID: 15485779	2004
[A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University\| PubMed ID: 17062361	2006
[Comparison of clinical outcomes between unrelated donor peripheral blood stem cell transplantation and bone marrow transplantation for leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 17172125	2006
[A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia]. Zhonghua nei ke za zhi\| PubMed ID: 17445441	2007
[Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation]. Zhonghua yi xue za zhi\| PubMed ID: 18396625	2007
[Effects of graft compositions on hematopoietic reconstitution and graft-versus-host disease in related donor peripheral blood stem cell transplantation]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 18844073	2008
[A clinical study of chronic disseminated candidiasis in patients with acute leukemia]. Zhonghua nei ke za zhi\| PubMed ID: 19040062	2008
[Immunol reconstitution after autologous purified CD34+ cells transplantation in patients with systemic lupus erythematosus]. Zhonghua nei ke za zhi\| PubMed ID: 19080297	2008
Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation. Hematology (Amsterdam, Netherlands)\| PubMed ID: 19298716	2009
[Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation]. Zhonghua yi xue za zhi\| PubMed ID: 19567075	2009
Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a singl... Annals of hematology\| PubMed ID: 20872002	2011
Simultaneous analysis of telomere length and cell surface antigen in leukemia by multicolor Flow-FISH. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 21176337	2010
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis. Blood cells, molecules & diseases\| PubMed ID: 21212006	2011
Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrosp... International journal of hematology\| PubMed ID: 21387092	2011
[Multiprobe fluorescence in situ hybridization panel in detection of the common cytogenetic abnormalities of acute myeloid leukemia]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology\| PubMed ID: 21638933	2011
[Serum α1-acid glycoprotein, imatinib concentration and efficacy in chronic myeloid leukemia patients]. Zhonghua yi xue za zhi\| PubMed ID: 22093988	2011
[Long-term outcomes of nilotinib treatment for chronic myelogenous leukemia patients with imatinib resistance or intolerance]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University\| PubMed ID: 22820586	2012
Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens. Annals of hematology\| PubMed ID: 23274355	2013
[Comparison of clinical implications of p16 deletion in childhood and adult B-lineage acute lymphoblastic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 23688747	2013
Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation. PloS one\| PubMed ID: 23823695	2013
[Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase]. Zhonghua yi xue za zhi\| PubMed ID: 24417923	2013
Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma. Leukemia research\| PubMed ID: 24713260	2014
The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression. Journal of hematology & oncology\| PubMed ID: 24739401	2014
Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 24769013	2014
[Effect of intermediate-dose cytarabine on mobilization of peripheral blood hematopoietic stem cell in acute myeloid leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 25052597	2014
Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma\| PubMed ID: 25175043	2015
[Clinical analysis of acute heart failure's risk factor for chronic myelogenous leukemia patient during the early stage of allogeneic hematopoietic stem cell transplantation]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 25687069	2015
The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma. PloS one\| PubMed ID: 25974110	2015
[Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 26913389	2016
Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP. International journal of hematology\| PubMed ID: 27393279	2016
The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP. Scientific reports\| PubMed ID: 29051524	2017
Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget\| PubMed ID: 29100345	2017
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood\| PubMed ID: 30104217	2018
Biology of Tumor Associated Macrophages in Diffuse Large B Cell Lymphoma. DNA and cell biology\| PubMed ID: 30403536	2018
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30862694	2019
Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP. Scientific reports\| PubMed ID: 31053761	2019
Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation. Bone marrow transplantation\| PubMed ID: 31645666	2020
Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma. International journal of hematology\| PubMed ID: 31993938	2020
Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma. Frontiers in oncology\| PubMed ID: 33585232	2020
LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p. Cancer management and research\| PubMed ID: 33958893	2021
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China. Leukemia & lymphoma\| PubMed ID: 34105439	2021
Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial. Circulation\| PubMed ID: 34503349	2022
Partial immunoparesis contributes to risk of early infections in patients with multiple myeloma. Translational cancer research\| PubMed ID: 35116375	2021
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a ph... BMC medicine\| PubMed ID: 35379237	2022
CD43 is an adverse prognostic factor in newly diagnosed multiple myeloma. Leukemia & lymphoma\| PubMed ID: 35819872	2022
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments. Annals of hematology\| PubMed ID: 36949293	2023
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria. The Lancet regional health. Western Pacific\| PubMed ID: 37283978	2023
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes. Haematologica\| PubMed ID: 37706332	2024
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study. BMJ open\| PubMed ID: 38159939	2023
Metabolic tumor volume from baseline [18 F]FDG PET/CT at diagnosis improves the IPI stratification in patients with diffuse large B-cell lymphoma. Annals of hematology\| PubMed ID: 39222121	2024
Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivot... Journal of translational medicine\| PubMed ID: 40426201	2025
Low peripheral blood B lymphocyte count predicts poor outcome in patients with multiple myeloma. Immunobiology\| PubMed ID: 40639196	2025
Development and validation of a prognostic staging system for primary plasma cell leukemia. Journal of hematology & oncology\| PubMed ID: 40660267	2025
Prognostic Performance of the FLAMB Model in Primary Gastric Diffuse Large B-Cell Lymphoma. British journal of hospital medicine (London, England : 2005)\| PubMed ID: 40847967	2025